ExpreS2ion Biotech Holding AB Financial Overview
ExpreS2ion Biotech Holding AB's market cap is currently €5.39M. The company's EPS TTM is €-0.292668417; its P/E ratio is -0.87; ExpreS2ion Biotech Holding AB is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
